C
Candel Therapeutics, Inc. (CADL)
NGM – Real Time Price. Currency in USD
8.72
-0.13 (-1.47%)
At close: May 12, 2026, 4:00 PM EDT
8.31
-0.41 (-4.65%)
After-hours: May 12, 2026, 7:57 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
8.72
-0.13 (-1.47%)
At close: May 12, 2026, 4:00 PM EDT
8.31
-0.41 (-4.65%)
After-hours: May 12, 2026, 7:57 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 13.49 | 6.05 | 10 | |
| Quick ratio | 13.49 | 5.63 | 10 | |
| Debt to Equity | 0.94 | 0.30 | 6.0 | |
| Debt to Assets | 0.39 | 1.04 | 6.0 | |
| Interest coverage | -11.12 | -16.91 | 1.0 | |
| Weighted average score | 6.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 125K | N/A | N/A | N/A | N/A |
| Gross Profit | -862K | -1M | -990K | -845K | -845K |
| Operating Income | -35M | -38M | -33M | -48M | -48M |
| Net Income | -19M | -38M | -55M | -38M | -38M |
| EBITDA | -34M | -37M | -32M | -47M | -47M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -327.57 | 1.0 |
| Next quarter | N/A | -234.86 | 1.0 |
| Current year | N/A | -74.37 | 1.0 |
| Next year | N/A | 27.39 | 5.5 |
| Weighted average score | 2.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -161.73 | -157.13 | -5.74 | 3.3 |
| Y/Y | 999 | -109.58 | -34.99 | -88.7 | 3.3 |
| 3y average | 632.67 | -38.82 | -25.23 | -9.27 | 3.3 |
| 5y average | 379.6 | -34.56 | -2.43 | -38.37 | 3.3 |
| Weighted average score | 3.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $119.7M significantly exceed its total debt $49.0M, ensuring strong financial flexibility
Total current assets $121.4M exceed Total current liabilities $9.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.9) is near the industry average, reflecting balanced leverage
Interest coverage ratio (-11.1x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$11.0M limits the company's ability to reinvest or pay down debt